CD33 and myelodysplastic syndrome: SBSN mRNA was significantly enriched in early‐stage myeloid‐derived suppressor cells [eMDSCs; Lin− (CD3, 14, 16, 19, 20, 56) HLA‐DR−, CD33+] of MDS patients.